|
Mixed-methods clinical trial to evaluate the feasibility of the CURATE.AI optimised digital cognitive rehabilitation therapeutic (COR-Tx) in patients post brain radiotherapy. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - National University of Singapore |
|
|
|
Consulting or Advisory Role - Bayer |
Speakers' Bureau - Stratpharma |
Research Funding - Stratpharma (Inst) |
|
|
Patents, Royalties, Other Intellectual Property - National University of Singapore (Inst) |
|
|
No Relationships to Disclose |
|
Balamurugan A. Vellayappan |
Travel, Accommodations, Expenses - Elekta |